Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 16.26% |
| 3 | Financials | 11.97% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
SiTime
SITM
$17.5B
| $1.34M | ﹤0.01% |
13,393
-39,715
| -75% | -$3.76M |
|
|
SWI
1452
DELISTED
SolarWinds Corporation Common Stock
SWI
| $1.33M | ﹤0.01% |
144,629
-124,453
| -46% | -$1.09M |
|
1453
Horace Mann Educators
HMN
$2.07B
| $1.33M | ﹤0.01% |
35,462
-1,913
| -5% | -$72.1K |
|
1454
Merit Medical Systems
MMSI
$5.39B
| $1.32M | ﹤0.01% |
18,678
-24,598
| -57% | -$1.64M |
|
1455
Hovnanian Enterprises
HOV
$739M
| $1.32M | ﹤0.01% |
31,257
+16,654
| +114% | +$706K |
|
1456
EXL Service
EXLS
$5.71B
| $1.31M | ﹤0.01% |
38,805
+1,485
| +4% | +$51.6K |
|
1457
AptarGroup
ATR
$8.57B
| $1.31M | ﹤0.01% |
11,913
-10,950
| -48% | -$1.12M |
|
1458
Rexford Industrial Realty
REXR
$8.4B
| $1.3M | ﹤0.01% |
23,921
+1,345
| +6% | +$72.5K |
|
1459
Merchants Bancorp
MBIN
$2.48B
| $1.3M | ﹤0.01% |
53,626
+11,457
| +27% | +$279K |
|
1460
Oil States International
OIS
$501M
| $1.3M | ﹤0.01% |
174,449
-39,992
| -19% | -$247K |
|
|
KAMN
1461
DELISTED
Kaman Corp
KAMN
| $1.29M | ﹤0.01% |
58,056
+12,343
| +27% | +$299K |
|
1462
Champion Homes
SKY
$4.97B
| $1.29M | ﹤0.01% |
25,084
-8,337
| -25% | -$444K |
|
1463
Bloom Energy
BE
$60.1B
| $1.29M | ﹤0.01% |
67,479
+56,701
| +526% | +$1.11M |
|
|
PFC
1464
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.28M | ﹤0.01% |
47,599
+12,576
| +36% | +$352K |
|
1465
Valaris
VAL
$5.96B
| $1.28M | ﹤0.01% |
18,892
+1,562
| +9% | +$97.5K |
|
1466
Tidewater
TDW
$4.62B
| $1.27M | ﹤0.01% |
34,468
+12,377
| +56% | +$377K |
|
|
ESGR
1467
DELISTED
Enstar Group
ESGR
| $1.27M | ﹤0.01% |
5,495
-914
| -14% | -$186K |
|
1468
AES
AES
$10.5B
| $1.27M | ﹤0.01% |
44,245
-17,757
| -29% | -$479K |
|
1469
Insulet
PODD
$10.1B
| $1.26M | ﹤0.01% |
4,367
+19
| +0.4% | +$5.24K |
|
1470
First Internet Bancorp
INBK
$250M
| $1.26M | ﹤0.01% |
51,977
+7,631
| +17% | +$202K |
|
1471
CVB Financial
CVBF
$3.95B
| $1.26M | ﹤0.01% |
48,994
+10,099
| +26% | +$275K |
|
1472
GoodRx Holdings
GDRX
$1.17B
| $1.26M | ﹤0.01% |
269,657
+94,041
| +54% | +$463K |
|
1473
Health Catalyst
HCAT
$120M
| $1.25M | ﹤0.01% |
118,036
+42,652
| +57% | +$412K |
|
1474
BancFirst
BANF
$3.78B
| $1.24M | ﹤0.01% |
14,114
+1,626
| +13% | +$154K |
|
1475
Stride
LRN
$3.54B
| $1.24M | ﹤0.01% |
39,716
+25,468
| +179% | +$935K |
|
Similar funds
Cliff Asness's Q4 2022 Portfolio in Review
As of Q4 2022, Cliff Asness held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Cliff Asness's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Cliff Asness's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- Cliff Asness added most to Humana in Q4 2022, an estimated $111M increase.
- Cliff Asness's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- Cliff Asness fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- Cliff Asness's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- Cliff Asness opened 170 new positions and closed 150 in Q4 2022.
- Cliff Asness's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.